Search - tctmd.com

Displaying 1 - 20 of 23

Sort: Relevancy | Date

News Daily News

High-Sensitivity Troponin Assays May Help Cut Down on Unnecessary Stress Tests, Study Suggests

Todd Neale

November 05, 2018

News Daily News

Coronary CTA for Suspected CAD Shows Advantages in Predicting Hard Outcomes Over 10 Years

Yael L. Maxwell

October 23, 2018

News Daily News

Plaque Characteristics on OCT Offer Clues About Atherosclerotic Causes of MINOCA

Caitlin E. Cox

October 23, 2018

Presentation TCT 2018

DEFERRAL Meta-Analysis: Outcomes after FFR-based Deferred Revascularization of Nonculprit Stenoses in Acute Coronary Syndromes vs Stable Coronary Artery Disease

Presenter: Nick Curzen, Nils Johnson, Javier Escaned

September 22, 2018

Presentation TCT 2018

TCT-38: Impact of FFRCT on Decision Making and Outcomes in Stable Coronary Artery Disease in North America: Results of the International ADVANCE Registry

Presenter: Javier Escaned, Tim P. Van de Hoef, Koen Nieman

September 21, 2018

News Conference News ESC 2018

My Takeaways From ESC 2018: Good or Bad, the Luxury of New Data Begets Cries for More

Shelley Wood

September 14, 2018

News Conference News ESC 2018

New ESC/EACTS Revascularization Guidelines Make Room for Radial First, STICH, and DES for All

Michael O'Riordan

August 29, 2018

News Daily News

‘Immediate’ Return to Normal Flow Post-PCI in ORBITA-Like Patients

Michael O'Riordan

August 23, 2018

News Conference News SCCT 2018

How Will High-Sensitivity Troponin Tests Affect CTA Use in the ED?

Yael L. Maxwell

July 24, 2018

News Conference News SCCT 2018

Where Progress Meets Payment: Cardiac CT Advocates Debate the Need for an NCD

Yael L. Maxwell

July 19, 2018

News Daily News

ORBITA Redux: Lancet Correspondence Takes Talk of the Sham-Controlled PCI Trial to Further Heights

Michael O'Riordan

July 10, 2018

News Daily News

Coronary CTA May Provide Novel Means of Predicting ACS Risk: ICONIC Study

L.A. McKeown

June 01, 2018

News Conference News EuroPCR 2018

Modest Benefit of PCI Over Medical Therapy in Patients With ‘Grey Zone’ FFR Lesions

Michael O'Riordan

May 23, 2018

Presentation EuroPCR 2018

Five-year Outcomes with PCI Guided by Fractional Flow Reserve in Patients with Stable Coronary Artery Disease (FAME 2)

Presenter: Panagiotis Xaplanteris

May 23, 2018

News Conference News EuroPCR 2018

FFR in PCI for Stable CAD: Lasting Benefit Shown by FAME 2, SCAAR Data

Caitlin E. Cox

May 22, 2018

News Conference News EuroPCR 2018

New ORBITA Insights: Invasive Physiology Tests Track Closely With Ischemia, but Not Symptom Improvement

Shelley Wood

May 22, 2018

Presentation EuroPCR 2018

ORBITA: A Physiology-stratified Analysis of the Impact of FFR and iFR on Efficacy of Coronary Angioplasty in Stable Coronary Artery Disease

Presenter: Rasha Al-Lamee

May 22, 2018

News Conference News EuroPCR 2018

FFR-Guided PCI Reduces Risk of Death/MI Compared With Medical Therapy: Pooled Analysis

Michael O'Riordan

May 22, 2018

News Conference News EuroPCR 2018

EuroPCR 2018: Stable CAD, Functional Tests, and Renal Denervation Take Center Stage

Shelley Wood

May 17, 2018

News Daily News

iFR Pullback Provides Roadmap for CAD Severity, Predicts Hemodynamics Post-PCI

Caitlin E. Cox

April 17, 2018

Advertisement

High-Sensitivity Troponin Assays May Help Cut Down on Unnecessary Stress Tests, Study Suggests

Coronary CTA for Suspected CAD Shows Advantages in Predicting Hard Outcomes Over 10 Years

Plaque Characteristics on OCT Offer Clues About Atherosclerotic Causes of MINOCA

DEFERRAL Meta-Analysis: Outcomes after FFR-based Deferred Revascularization of Nonculprit Stenoses in Acute Coronary Syndromes vs Stable Coronary Artery Disease

TCT-38: Impact of FFRCT on Decision Making and Outcomes in Stable Coronary Artery Disease in North America: Results of the International ADVANCE Registry

My Takeaways From ESC 2018: Good or Bad, the Luxury of New Data Begets Cries for More

New ESC/EACTS Revascularization Guidelines Make Room for Radial First, STICH, and DES for All

‘Immediate’ Return to Normal Flow Post-PCI in ORBITA-Like Patients

How Will High-Sensitivity Troponin Tests Affect CTA Use in the ED?

Where Progress Meets Payment: Cardiac CT Advocates Debate the Need for an NCD

ORBITA Redux: Lancet Correspondence Takes Talk of the Sham-Controlled PCI Trial to Further Heights

Coronary CTA May Provide Novel Means of Predicting ACS Risk: ICONIC Study

Modest Benefit of PCI Over Medical Therapy in Patients With ‘Grey Zone’ FFR Lesions

Five-year Outcomes with PCI Guided by Fractional Flow Reserve in Patients with Stable Coronary Artery Disease (FAME 2)

FFR in PCI for Stable CAD: Lasting Benefit Shown by FAME 2, SCAAR Data

New ORBITA Insights: Invasive Physiology Tests Track Closely With Ischemia, but Not Symptom Improvement

ORBITA: A Physiology-stratified Analysis of the Impact of FFR and iFR on Efficacy of Coronary Angioplasty in Stable Coronary Artery Disease

FFR-Guided PCI Reduces Risk of Death/MI Compared With Medical Therapy: Pooled Analysis

EuroPCR 2018: Stable CAD, Functional Tests, and Renal Denervation Take Center Stage

iFR Pullback Provides Roadmap for CAD Severity, Predicts Hemodynamics Post-PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content